Structures by: Sugawara Y.
Total: 10
4a
C40H20F8N4
Organic letters (2013) 15, 13 3202-3205
a=20.8969(19)Å b=25.977(2)Å c=14.1722(13)Å
α=90.00° β=129.736(2)° γ=90.00°
C56H48F8N4
C56H48F8N4
Organic letters (2013) 15, 13 3202-3205
a=8.695(4)Å b=9.355(5)Å c=13.874(7)Å
α=104.830(8)° β=90.259(6)° γ=90.583(6)°
Disodium guanosine 5'-monophosphate tetrahydrate
2(Na),(C10H12N5O8P2),4(H2O)
Acta Crystallographica Section C (2018) 74, 10 1153-1159
a=5.5965(8)Å b=10.7222(17)Å c=15.710(3)Å
α=90° β=98.796(9)° γ=90°
C38H69NO13,CH4O
C38H69NO13,CH4O
Acta Crystallographica Section C (1993) 49, 6 1227-1230
a=19.979(2)Å b=24.115(3)Å c=8.9980(14)Å
α=90° β=90° γ=90°
C13H8O2
C13H8O2
Acta Crystallographica Section C (1992) 48, 4 680-683
a=9.089(2)Å b=17.737(2)Å c=14.265(2)Å
α=90° β=125.65(2)° γ=90°
L-leucyl-glycine dihydrate
3(C8H16N2O3),2(H2O)
Acta Crystallographica Section C (2012) 68, 12 o498-o501
a=8.735(5)Å b=15.540(10)Å c=24.238(15)Å
α=90.00° β=90.00° γ=90.00°
[(4<i>S</i>)-2,2-dimethyl-4-(2-methylpropyl)- 5-oxoimidazolidin-3-ium-1-yl]acetate
C11H20N2O3
Acta Crystallographica Section C (2012) 68, 12 o498-o501
a=6.0060(14)Å b=6.8782(18)Å c=7.9717(18)Å
α=90.202(11)° β=98.272(8)° γ=107.193(11)°
2-{2-[(2<i>R</i>)-2-Amino-4-methylpentanamido]acetamido}acetic acid
C10H19N3O4
Acta Crystallographica Section E (2013) 69, 5 o660
a=5.391(5)Å b=11.742(10)Å c=19.975(16)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(4,5-Dibromo-[1,3]dithiol-2-ylidene)-1,3-benzodithiol-5-yl]- 4,4,5,5-tetramethyl imidazoline-3-oxide-1-oxyl
C17H15Br2N2O2S4
Journal of the American Chemical Society (2010) 132, 4528-4529
a=33.311(6)Å b=33.311(6)Å c=7.6091(18)Å
α=90.00° β=90.00° γ=90.00°
(C41H35NO4)2(C3OH6)
(C41H35NO4)2(C3OH6)
Journal of the American Chemical Society (1996) 118, 3100-3107
a=10.941(9)Å b=13.861(10)Å c=13.141(8)Å
α=90.00° β=99.89(5)° γ=90.00°